Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay

References

• BarriosE, GarauM. Cáncer: magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos. Anales de la Facultad de Medicina. 2017;4:9–46. doi:10.25184/anfamed2017.4.1.2
   Google Scholar
• Comision Honoraria de Lucha contra el Cancer. Informe Anual. Periodo 2011–2015 (Fecha acceso: 6/05/2019). Available from: http://www.comisioncancer.org.uy/uc_209_1.html. Accessed December2, 2021.
   Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717. doi:10.1016/S0140-6736(05)66544-015894097
   PubMed Web of Science ®Google Scholar
• LohrischC, PaltielC, GelmonK, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24:4888–4894. doi:10.1200/JCO.2005.01.608917015884
   PubMed Web of Science ®Google Scholar
• ColleoniM, BonettiM, CoatesAS, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol. 2000;18:584–590. doi:10.1200/JCO.2000.18.3.58410653873
   PubMed Web of Science ®Google Scholar
• BiagiJJ, RaphaelM, KingWD, KongW, BoothCM, MackillopWJ. The effect of delay in time to adjuvant chemotherapy (TTAC) on survival in breast cancer (BC): a systematic review and meta-analysis. J Clin Oncol. 2011;29(15_suppl):1128.
   Web of Science ®Google Scholar
• Gagliato DdeM, Gonzalez-AnguloAM, LeiX, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014;32:735–744. doi:10.1200/JCO.2013.49.769324470007
   PubMed Web of Science ®Google Scholar
• BuzdarAU, SmithTL, PowellKC, BlumenscheinGR, GehanEA. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat. 1982;2(2):163–169. doi:10.1007/BF018064526897369
   PubMedGoogle Scholar
• Jara SánchezC, RuizA, MartínM, et al. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM). Breast Cancer Res Treat. 2007;101(2):215–223. doi:10.1007/s10549-006-9282-016823507
   PubMed Web of Science ®Google Scholar
• BellonJR, ComeSE, GelmanRS, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005;23(9):1934–1940. doi:10.1200/JCO.2005.04.03215774786
   PubMed Web of Science ®Google Scholar
• KaufmanCS, ShockneyL, RabinowitzB, et al. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377–385. doi:10.1245/s10434-009-0729-519834768
   PubMed Web of Science ®Google Scholar
• Del TurcoMR, PontiA, BickU, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46:2344–2356. doi:10.1016/j.ejca.2010.06.11920675120
   PubMed Web of Science ®Google Scholar
• DeschCE, McNiffKK, SchneiderEC, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol. 2008;26:3631–3637. doi:10.1200/JCO.2008.16.506818640941
   PubMed Web of Science ®Google Scholar
• BleicherRJ, RuthK, SigurdsonER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–339. doi:10.1001/jamaoncol.2015.450826659430
   PubMed Web of Science ®Google Scholar
• VandergriftJL, NilandJC, TheriaultRL, et al. Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst. 2013;105:104–112. doi:10.1093/jnci/djs50623264681
   PubMedGoogle Scholar
• Chavez-MacGregorM, ClarkeCA, LichtensztajnDY, GiordanoSH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2015;2:322–329. doi:10.1001/jamaoncol.2015.3856
   Web of Science ®Google Scholar
• YuKD, HuangS, ZhangJX, LiuGY, ShaoZM. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:240. doi:10.1186/1471-2407-13-24023679207
   PubMed Web of Science ®Google Scholar
• Smith-GrazianiD, LeiX, GiordanoSH, ZhaoH, KaruturiM, Chavez-MacGregorM. Delayed initiation of adjuvant chemotherapy in older women with breast cancer. Cancer Med. 2020;9:6961–6971. doi:10.1002/cam4.336332767723
   PubMed Web of Science ®Google Scholar
• KupstasAR, HoskinTL, DayCN, HabermannEB, BougheyJC. Effect of surgery type on time to adjuvant chemotherapy and impact of delay on breast cancer survival: a national cancer database analysis. Ann Surg Oncol. 2019;26(10):3240–3249. doi:10.1245/s10434-019-07566-731332635
   PubMed Web of Science ®Google Scholar
• ShannonC, AshleyS, SmithIE. Does timing of adjuvant chemotherapy for early breast cancer influence survival?J Clin Oncol. 2003;21(20):3792–3797. doi:10.1200/JCO.2003.01.07314551298
   PubMed Web of Science ®Google Scholar
• HershmanDL, WangX, McBrideR, JacobsonJS, GrannVR, NeugutAI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99(3):313–321. doi:10.1007/s10549-006-9206-z16583264
   PubMed Web of Science ®Google Scholar
• MosalamNA, El AzizMH, SaadAS, MohamedAW. The impact of adjuvant chemotherapy initiation time on the outcome of breast cancer. J Oncol Transl Res. 2017;3:113. doi:10.4172/2476-2261.1000113
   Google Scholar